S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
Log in

OTCMKTS:SKVI - Skinvisible Stock Price, Forecast & News

$0.09
0.00 (0.00 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$0.09
Now: $0.09
$0.09
50-Day Range
$0.04
MA: $0.08
$0.19
52-Week Range
$0.01
Now: $0.09
$0.87
Volume3,503 shs
Average Volume445 shs
Market Capitalization$263,900.00
P/E RatioN/A
Dividend YieldN/A
Beta0.87
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic markets. Its non-dermatological formulations offer solutions for women's health, pain management, and others markets. The company offers sunless tanning, anti-aging, and sunscreen products. Skinvisible, Inc. also licenses its products to manufacturers and marketers of brands internationally, as well as sells directly in the market; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was founded in 1998 and is based in Las Vegas, Nevada.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SKVI
CUSIPN/A
Phone702-433-7154

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$70,000.00
Cash Flow$0.23 per share
Book Value($1.63) per share

Profitability

Net Income$160,000.00
Net Margins-3,243.81%

Miscellaneous

Employees3
Market Cap$263,900.00
Next Earnings DateN/A
OptionableNot Optionable

Receive SKVI News and Ratings via Email

Sign-up to receive the latest news and ratings for SKVI and its competitors with MarketBeat's FREE daily newsletter.


Skinvisible (OTCMKTS:SKVI) Frequently Asked Questions

What is Skinvisible's stock symbol?

Skinvisible trades on the OTCMKTS under the ticker symbol "SKVI."

Has Skinvisible been receiving favorable news coverage?

News coverage about SKVI stock has been trending very negative this week, according to InfoTrie. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Skinvisible earned a media sentiment score of -3.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Skinvisible.

Who are some of Skinvisible's key competitors?

What other stocks do shareholders of Skinvisible own?

Who are Skinvisible's key executives?

Skinvisible's management team includes the folowing people:
  • Mr. Terry H. Howlett, Pres, CEO, CFO & Director (Age 71)
  • Ms. Doreen McMorran, Head/VP of Bus. Devel. & Marketing (Age 56)
  • Dr. Geert Cauwenbergh, Head of International Advisory Board (Age 65)

How do I buy shares of Skinvisible?

Shares of SKVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Skinvisible's stock price today?

One share of SKVI stock can currently be purchased for approximately $0.09.

How big of a company is Skinvisible?

Skinvisible has a market capitalization of $263,900.00 and generates $70,000.00 in revenue each year. Skinvisible employs 3 workers across the globe.View Additional Information About Skinvisible.

What is Skinvisible's official website?

The official website for Skinvisible is http://www.skinvisible.com/.

How can I contact Skinvisible?

Skinvisible's mailing address is 6320 S SANDHILL ROAD SUITE 10, LAS VEGAS NV, 89120. The company can be reached via phone at 702-433-7154 or via email at [email protected]


MarketBeat Community Rating for Skinvisible (OTCMKTS SKVI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  39 (Vote Underperform)
Total Votes:  88
MarketBeat's community ratings are surveys of what our community members think about Skinvisible and other stocks. Vote "Outperform" if you believe SKVI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SKVI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel